Download video

Data on KRAS inhibitors in lung cancer at WCLC 2022

141 views

VJOncology

11 days ago

Data on KRAS inhibitors in lung cancer at WCLC 2022

Data on KRAS inhibitors in lung cancer at WCLC 2022

Managing Side Effects of New Treatments for Small Cell Lung Cancer
14:57
Managing Side Effects of New Treatments for Small Cell Lung Cancer
by OncBrothers: Practice-Changing Cancer Discussions
Latest Clinical Data for First-line Maintenance and R\/R Small-Cell Lung Cancer (SCLC)
16:30
Latest Clinical Data for First-line Maintenance and R\/R Small-Cell Lung Cancer (SCLC)
by OncBrothers: Practice-Changing Cancer Discussions
Real-world clinical and molecular NSCLC data in Biomarkers ATLAS
0:48
Real-world clinical and molecular NSCLC data in Biomarkers ATLAS
by VJOncology
Lung Cancer Survival Prediction
1:18
Lung Cancer Survival Prediction
by JAMA Network
EP52: From Transcriptomics to Proteomics: A Use Case in Lung Adenocarcinoma
32:36
EP52: From Transcriptomics to Proteomics: A Use Case in Lung Adenocarcinoma
by BioTuring Team
Extensive Stage Small Cell Lung Cancer
30:14
Extensive Stage Small Cell Lung Cancer
by Rad Onc Talks
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
21:06
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
by OncBrothers: Practice-Changing Cancer Discussions
What Is The Future Of FGFR Inhibitors? - Oncology Support Network
4:02
What Is The Future Of FGFR Inhibitors? - Oncology Support Network
by Oncology Support Network
Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi
17:40
Challenging Cases with Metastatic EGFR Mutated Non-Small Cell Lung Cancer with Dr. Eric Singhi
by OncBrothers: Practice-Changing Cancer Discussions
Oncogene-addicted NSCLC
5:48
Oncogene-addicted NSCLC
by COR2ED The Heart of Medical Education
Real-world outcomes of IO intensification in advanced NSCLC
1:33
Real-world outcomes of IO intensification in advanced NSCLC
by VJOncology
IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)
25:31
IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)
by OncBrothers: Practice-Changing Cancer Discussions
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: An Update from ASCO 2022
19:43
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: An Update from ASCO 2022
by Clinical Care Options
How to Treat Early Stage Non-Small Cell Lung Cancer in 2025
20:31
How to Treat Early Stage Non-Small Cell Lung Cancer in 2025
by OncBrothers: Practice-Changing Cancer Discussions
Key clinical and translational updates in mesothelioma at WCLC 2025
3:07
Key clinical and translational updates in mesothelioma at WCLC 2025
by VJOncology
Promising updates in small cell lung cancer at WCLC 2025
1:13
Promising updates in small cell lung cancer at WCLC 2025
by VJOncology
Treatment options for pregnant patients with non-small cell lung cancer
1:11
Treatment options for pregnant patients with non-small cell lung cancer
by VJOncology
The evolving role of datopotamab deruxtecan in lung cancer
1:16
The evolving role of datopotamab deruxtecan in lung cancer
by VJOncology
Treatment Options for Limited-Stage Small Cell Lung Cancer - 2025 Lung Cancer Video Library
4:35
Treatment Options for Limited-Stage Small Cell Lung Cancer - 2025 Lung Cancer Video Library
by Global Resource for Advancing Cancer Education
CheckMate 816: what does the data tell us?
2:35
CheckMate 816: what does the data tell us?
by VJOncology